132 related articles for article (PubMed ID: 6567527)
1. Discriminant analysis of Hodgkin's disease and non-Hodgkin's lymphomas by age and serum proteins.
Merucci P; Taggi F; Marolla A; Abbolito MR; Vitelli G; Marolla P; Meliffi L; Chiarotti F; Ippolito FM; Ameglio F
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1243-7. PubMed ID: 6567527
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
Casamassima A; Addabbo L; Caporusso L; Lorusso V
Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
[TBL] [Abstract][Full Text] [Related]
3. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
[No Abstract] [Full Text] [Related]
4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
5. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
Sirsat AV; Raste AS; Talavdekar RV; Advani SH
Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
[No Abstract] [Full Text] [Related]
6. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
7. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?
Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S
J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908
[TBL] [Abstract][Full Text] [Related]
8. Fiberoptic bronchoscopy in patient with Hodgkin's and non-Hodgkin's lymphomas.
Gribetz AR; Chuang MT; Teirstein AS
Cancer; 1980 Sep; 46(6):1476-8. PubMed ID: 7417947
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
10. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
[TBL] [Abstract][Full Text] [Related]
11. Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and non-Hodgkin's and Hodgkin's disease. An evaluation of differences.
Drent M; Wagenaar SS; Mulder PH; van Velzen-Blad H; Diamant M; van den Bosch JM
Chest; 1994 Feb; 105(2):514-9. PubMed ID: 7905815
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
13. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
[TBL] [Abstract][Full Text] [Related]
14. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin's and non-Hodgkin's lymphomas masquerading as "idiopathic" liver granulomas.
Aderka D; Kraus M; Avidor I; Sidi Y; Weinberger A; Pinkhas J
Am J Gastroenterol; 1984 Aug; 79(8):642-4. PubMed ID: 6465111
[TBL] [Abstract][Full Text] [Related]
16. Behavior of total serum complement in Hodgkin's disease and other malignant lymphomas.
ROTTINO A; LEVY AL
Blood; 1959 Mar; 14(3):246-54. PubMed ID: 13628822
[No Abstract] [Full Text] [Related]
17. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
Kim H; Nathwani BN; Rappaport H
Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of laparoscopy with liver biopsy in the assessment of liver involvement at diagnosis of Hodgkin's and non-Hodgkin's lymphomas.
Sans M; Andreu V; Bordas JM; Llach J; López-Guillermo A; Cervantes F; Bruguera M; Mondelo F; Montserrat E; Terés J; Rodés J
Gastrointest Endosc; 1998 May; 47(5):391-5. PubMed ID: 9609433
[TBL] [Abstract][Full Text] [Related]
19. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
Schreiber DP; Jacobs C; Rosenberg SA; Cox RS; Hoppe RT
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):31-6. PubMed ID: 3838166
[TBL] [Abstract][Full Text] [Related]
20. Serum proteins in Hodgkin's disease and malignant lymphoma.
ARENDS T; COONRAD EV; RUNDLES RW
Am J Med; 1954 Jun; 16(6):833-41. PubMed ID: 13158372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
